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Envelope viruses maturate by macromolecule assembly and budding. To investigate these steps, we generated virus-like particles (VLPs)
by co-expression of structural proteins of Sendai virus (SeV), a prototype of the family Paramyxoviridae. Simultaneous expression of matrix
(M), nucleo- (N), fusion (F), and hemagglutinin-neuraminidase (HN) proteins resulted in the generation of VLPs that had morphology and
density similar to those of authentic virus particles, although the efficiency of release from cells was significantly lower than that of the virus.
By using this VLP formation as a model of virus budding, roles of individual proteins in budding were investigated. The M protein was a
driving force of budding, and the F protein facilitated and the HN protein suppressed VLP release. Either of the glycoproteins, F or HN, as
well as the N protein, significantly shifted density of VLPs to that of virus particles, suggesting that viral proteins bring about integrity of
VLPs by protein–protein interactions. We further found that co-expression of a nonstructural protein, C, but not V, enhanced VLP release to
a level comparable to that of virus particles, demonstrating that the C protein plays a role in virus budding.
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Sendai virus (SeV), a prototype of the family Paramyx-
oviridae, is an enveloped virus with a nonsegmented nega-
tive-strand RNA genome. The SeV virion has two spike
glycoproteins on the lipid-containing envelope, the hemag-
glutinin-neuraminidase (HN) protein and the fusion (F)
protein. Lying underneath the envelope is the matrix (M)
protein, which bridges the viral glycoproteins and the inter-
nal nucleocapsid. The nucleocapsid has a helical structure
consisting of genomic RNA enwrapped with the nucleocap-
sid (N) protein, associated with RNA polymerase subunits,
the large (L) protein, and the phosphoprotein (P). Besides
these structural proteins, the P gene encodes the C proteins
and the V protein. The C proteins are a generic name of four
proteins, CV, C, Y1, and Y2, formed by the various start0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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shifted from that of the P protein. The V protein is synthe-
sized from an accessory mRNA generated by RNA editing
during transcription and containing an insertion of a pseu-
dotemplated G residue at a specific editing site. These
proteins are not basically incorporated into virions and are
termed nonstructural proteins (Lamb and Kolakofsky, 2001;
Nagai, 1999). SeV replicates in the cytoplasm and is released
from infected cells by assembly and budding at the plasma
membrane. Although the current model for assembly of the
paramyxovirus implicates the M protein as the principal
component promoting the budding of the virus particle
(Peeples, 1991; Yoshida et al., 1976, 1979), the underlying
mechanism of virion formation is still poorly understood.
Previous studies on retroviruses using the virus-like
particle (VLP) system have made great progress in identi-
fication of functional domains for budding in the gag protein
and in elucidation of their budding mechanisms (Accola et
al., 2000; reviewed in Freed, 2002). In the VLP system, the
F. Sugahara et al. / Virology 325 (2004) 1–102gag protein is released into the culture medium when
expressed in the absence of other viral proteins, forming
VLPs that resemble virus particles (Freed, 2002). In nega-
tive-strand RNA viruses, M protein-deficient viruses have
been generated by using the virus recovery system from
cDNA in rabies virus (Mebatsion et al., 1996), measles virus
(Cathomen et al., 1998), and SeV (Inoue et al., 2003a).
These viruses are invariably defective in virus budding.
Furthermore, expression of the M protein or its analogs in
the absence of other viral proteins leads to its release into
the medium in a lipid-containing vesicle, as was observed
for the M protein of vesicular stomatitis virus (VSV)
(Justice et al., 1995; Li et al., 1993; Sakaguchi et al.,
1999), M1 of influenza virus (Gomez-Puertas et al., 2000;
Latham and Galarza, 2001), and VP40 of Ebola virus (Harty
et al., 2000; Timmins et al., 2001). In VSV and Ebola virus,
ca. 20–40% of the M protein synthesized in cells was
released into the medium (Justice et al., 1995; Sakaguchi
et al., 1999; Timmins et al., 2001). The M protein of
parainfluenzavirus type 1 (PIV1), a paramyxovirus belong-
ing to the same genus Respirovirus as SeV, is also released
into the culture medium when expressed alone (Coronel et
al., 1999). Co-expression of M and N proteins causes
release of vesicles enclosing nucleocapsid-like structures
(Coronel et al., 1999). It has also been shown that expres-
sion of the SeV M protein results in its release from cells
(Sakaguchi et al., 1999; Takimoto et al., 2001). Moreover,
the F protein as well as the M protein has been shown to
form vesicles to be released when expressed alone, and
protein motifs necessary for the release, including putative
actin-binding motifs, have been identified (Takimoto et al.,
2001). However, a quantitative study on the release has not
been performed.
Schmitt et al. (2002) generated VLPs that resembled
authentic virus particles by expressing proteins of simian
virus 5 (SV5), a member of the genus Rubulavirus of the
family Paramyxoviridae, and demonstrated that expression
of the M protein alone was not sufficient for its release from
cells but that simultaneous expression of the M protein, N
protein, and one of the viral glycoproteins, F and HN
proteins, was necessary for efficient VLP release from cells.
The results of that study show that interactions among
multiple viral proteins, not the M protein alone, confer
budding competence on VLP, suggesting a different mecha-
nism of paramyxovirus budding.
To further clarify the mechanism of paramyxovirus
assembly and budding by using a VLP system, it is
important to investigate the effects of other viral proteins,
in addition to the M protein, on VLP formation. In the
present study, we generated VLPs by co-expressing SeV
proteins in various combinations, and we evaluated the
contribution of each viral protein to budding by quantifying
VLP release from cells. Furthermore, roles of each viral
protein in VLP formation towards an authentic virus particle
were also investigated by estimating density of the VLPs
and by electron microscopy. The results showed that the Mprotein was indeed a major driving force of SeV budding
and that the F and HN proteins had enhancing and suppres-
sive effects on budding, respectively. Furthermore, we show
that the four viral proteins M, N, F, and HN, are required for
formation of VLPs with density and morphology similar to
those of authentic SeV particles and that the C protein
enhances VLP release.Results
VLP formation by expression of SeV M, N, F, and HN
proteins
SeV M, N, F, and HN proteins were simultaneously
expressed in 293T cells and metabolically labeled with
[35S]cysteine and [35S]methionine. The culture medium
was then collected and directly fractionated by sucrose
floatation ultracentrifugation. Viral proteins in the floated
fraction showed that these four proteins were released in
the form of lipid-containing vesicles (Fig. 1A). Viral
proteins in the cells were also analyzed, and the fraction
of the released M protein was calculated as described in
Materials and methods. The released fraction was 3.6%,
which was ca. 1/5 of that of virus particles from infected
cells (18.3%) (Fig. 1A).
Sucrose density equilibrium ultracentrifugation of the
culture supernatant demonstrated that the M, N, F, and HN
proteins were concentrated to fraction 14 (density = 1.17–
1.20 g/ml), which was identical to that of authentic virus
particles (Fig. 1B). Electron microscopy with negative stain-
ing showed the existence of virus-like particles (VLPs) that
appeared to be similar to authentic virus particles (Fig. 1C).
Herring bone-like, nucleocapsid-like structures were also
found beside the VLPs (Fig. 1C). This finding is consistent
with a previously reported finding that expression of the SeV
N protein in cells resulted in generation of nucleocapsid-like
structures (Buchholz et al., 1993). The VLPs seem to contain
RNA actually because radioactivity was found at fractions
14–16 in [3H]uridine labeling (data not shown). These
results indicate that simultaneous expression of the M, N,
F, and HN proteins yielded VLPs with morphology and
density similar to those of actual virus particles, suggesting
that VLP formation can be a model for virus budding. The
release efficiency of the VLPs was, however, significantly
lower than that of SeV from infected cells.
Amounts of the N protein in the VLPs and virus particles
were compared with those of other viral proteins after
sucrose density equilibrium ultracentrifugation. Ratios of
N protein to M protein in fraction 14 in Fig. 1B were 1.6 for
the VLP and 0.7 for the SeV particle. The VLP was shown
to contain more N proteins than the amount in the SeV
particle. The ratios of other proteins in VLPs and SeV
particles appeared to be similar.
We added an exogenous neuraminidase to the medium to
prevent VLPs from being trapped on the cell surface by the
Fig. 1. Comparison of VLPs by co-expression of M, N, F, and HN proteins and SeV. (A) 293T cells were transfected with plasmids for expression of M, N, F,
and HN proteins or infected with SeVat an m.o.i. of 10 and labeled with [35S]cysteine and [35S]methionine from 24 to 48 h post-transfection. The medium was
then separated by sucrose floatation ultracentrifugation, and proteins in the floated fraction were analyzed by immunoprecipitation and SDS-PAGE. Proteins in
the cells were also analyzed, and the released fraction of the M protein is shown in the figure. F0: precursor of the F protein before proteolytic processing.
Proteins from 1/15 of the cell lysates and those from half of the medium were run in a lane. (B) The medium from the labeled cells was then separated by
sucrose density equilibrium ultracentrifugation in a 20–50% continuous gradient. Fractions were collected, and SeV proteins in each fraction were analyzed by
immunoprecipitation and SDS-PAGE. Density of fractions was measured by weighing each fraction. (C) The medium from transfected 293T cells was
concentrated by ultracentrifugation at 24000 rpm for 1 h through a 7% (w/w) sucrose cushion. The pellet was then suspended in PBS, processed for negative
staining, and observed by electron microscopy. Arrowheads indicate nucleocapsid-like structures.
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release by ca. 2-fold in some experiments, although it was
not always reproducible. The medium was supplemented
with neuraminidase in all of the experiments in this study.
Contribution of each SeV protein to VLP release from cells
We investigated the role of each SeV protein in VLP
formation. Expression of the M protein alone led to an
efficient release of M proteins into the medium (Fig. 2A).
The efficiency of the M protein release was calculated to be
14.5%. The F protein was also released but with less
efficiency (0.7%) (Fig. 2A). Only a trace amount of proteinswas released when either the N or HN protein was expressed
(Fig. 2A).
Expression of the F protein with the M protein increased
the released fractions of both proteins, especially that of the
F protein significantly (from 0.7% to 6.5%) (Fig. 2B),
suggesting a synergic effect of protein release. In contrast,
expression of the HN protein with the M protein resulted in
suppression of M protein release (from 14.5% to 0.6%),
although the released fraction of the HN protein itself was
slightly increased from 0.1% to 0.4%. Expression of the N
protein with the M protein also decreased the released
fraction of the M protein to 3.2%, while it increased the
released fraction of the N protein from 0.03% to 0.4% (Fig.
Fig. 2. Protein release by expression of single or double SeV proteins. A
single plasmid (A) or two plasmids (B) as indicated in the figure were
introduced into 293T cells and labeled with [35S]cysteine and [35S]methi-
onine from 24 to 48 h post-transfection. The vesicles released were
concentrated by sucrose floatation ultracentrifugation, and proteins were
analyzed by immunoprecipitation and SDS-PAGE. Proteins in the cells were
also analyzed, and protein release was calculated by each protein (A) and by
the M protein (B). Asterisk: protein release was calculated by the HN
protein. Proteins from 1/15 of the cell lysates and those from half of the
medium were run in a lane in these gels.
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vesicle release. Co-expression of the two glycoproteins, F
and HN, did not result in efficient release of these proteins
(Fig. 2B).
An apparent constant intracellular level of the M protein
in Fig. 2B does not seem to accord with the fact that thereleased fraction of M protein varied from 0.6% to 17.9%;
intracellular M protein level should vary in accordance with
the variation in the released fraction. This is due to the
sample amount loaded on the gel as described in Materials
and methods (1/15 of the cell lysates and half of the
medium). The difference between the amounts of M pro-
teins in cells was therefore compressed to 1/7.5, making it
difficult to detect the difference between levels of intracel-
lular M protein.
Expression of the M, N, F, and HN proteins resulted in
formation of a VLP as described above. Removal of the M
protein from this combination resulted in complete sup-
pression of VLP release, supporting the notion that the M
protein is a major driving force for release (Fig. 3A).
Removal of the F protein also reduced the released proteins
to 0.5%, indicating that the F protein has a release-promot-
ing effect (Fig. 3A). Removal of the N protein did not
significantly affect the efficiency of release in this case
(Fig. 3A). It is notable that without the HN protein, release
of the remaining proteins, M, F, and N proteins, was
enhanced (8.3%; Fig. 3A). An increase in amounts of
transfected HN plasmids resulted in greater suppression
of VLP release (Fig. 3B), confirming that the HN protein
has an inhibitory effect on release. The inhibitory effect
may not be due to cell toxicity of the HN protein because
viral protein synthesis appeared to be constant in the
transfected cells (Fig. 3B) and no apparent CPE was
observed (data not shown). For experiments in this study,
0.5 Ag of the HN plasmid was used to adjust the intracel-
lular expression level of HN protein to that in SeV-infected
cells.
Acceleration of VLP release by co-expression of the C
protein
Effects of nonstructural proteins, C and V proteins, on
the VLP release were further examined. Expression of the C
protein together with M, N, F, and HN proteins enhanced
VLP release by more than 2-fold (Fig. 4). The enhancement
was highly reproducible (Fig. 4), showing that the C protein
increased the efficiency of VLP release. In contrast, the V
protein did not have such an enhancing activity (data not
shown). The fraction of M released into VLPs formed by M,
N, F, HN, and C was 9.8%, almost half of the M fraction
released into SeV particles (Fig. 4).
Density and morphology of structures released by
expression of viral proteins in various combinations
We performed sucrose density equilibrium ultracentrifu-
gation to determine the density of released proteins. M
protein released by single expression showed a wide range
of densities, indicating heterogeneity of M protein-contain-
ing structures (Fig. 5). The M protein was found in
abundance in fractions 8 to 16 (1.09–1.22 g/ml). The M
protein was considered to be released in association with
Fig. 3. (A) Contribution of SeV proteins to VLP release from cells. 293T cells were transfected with multiple plasmids as indicated in the figure and labeled
with [35S]cysteine and [35S]methionine from 24 to 48 h post-transfection. The medium was then separated by sucrose floatation ultracentrifugation, and
proteins in the floated fraction were analyzed by immunoprecipitation and SDS-PAGE. Proteins in the cells were also analyzed, and protein release was
calculated by the M protein. (B) Effect of the HN protein on VLP release. The M, N, and F plasmids together with increasing amounts of the HN plasmid were
introduced into 293T cells, and proteins were analyzed. Proteins from 1/15 of the cell lysates and those from half of the medium were run in a lane in these gels.
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ultracentrifugation shifted the distribution (data not shown).
The singly expressed F protein was distributed in a narrowFig. 4. Effect of C protein on VLP release from cells. 293T cells were transfected
figure and labeled with [35S]cysteine and [35S]methionine from 24 to 48 h p
ultracentrifugation, and proteins in the floated fraction were analyzed by immu
similarly, and protein release was calculated by the M protein. Proteins from 1/15 o
graph indicates the ratio of fractions of M released into VLPs from four indepenrange around fraction 14 (1.17–1.20 g/ml) (Fig. 5), and
released N protein was slightly detected in a heavier
fraction, fraction 16 (1.20–1.22 g/ml) (Fig. 5).with multiple plasmids with or without the C plasmid as indicated in the
ost-transfection. The medium was then separated by sucrose floatation
noprecipitation and SDS-PAGE. Proteins in the cells were also analyzed
f the cell lysates and those from half of the medium were run in a lane. The
dent experiments. Error bar indicates standard deviation.
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these two proteins co-existed mainly in fractions 12 and 14
(Fig. 5, M + F). The distribution of the M protein was shifted
into these fractions (Fig. 5, M + F). A band between the M
and F0 proteins was considered to be h-actin because it
reacted with anti-h-actin antibody in immunoblotting (data
not shown) as described previously (Takimoto et al., 2001).
Expression of the N protein with the M protein resulted in
co-existence of N and M proteins in a fraction similar to that
when the N protein was singly expressed (Fig. 5, M + N). On
the other hand, a significant amount of the M protein was
found in fractions 8–12 (Fig. 5, M + N), probably having
been released independently of the release of the N protein.
The changes in distribution and amounts of released proteins
by co-expression suggest interactions between F and M
proteins and between M and N proteins. In contrast, simul-
taneous expression of F and N proteins caused no change in
protein release or in density distribution compared with those
in the case of single expressions (data not shown).
Triple expression of M, N, and F proteins caused co-
localization of these three proteins in fraction 14, suggesting
that a significant amount of these proteins interacted and
formed VLPs with density similar to that of authentic virusFig. 5. Distributions of densities of VLPs with an increasing number of plasmids
expression of multiple viral proteins (M + F, M + N, M + N + F, or M + N +
[35S]methionine from 24 to 48 h post-transfection. The medium was then separated
gradient. Fractions were taken and SeV proteins in each fraction were analyzed by i
protein in the results from each combination of plasmids in Fig. 1B (M + N + Fparticles (Fig. 5, M + N + F). On the other hand, some N
proteins were found in a heavier fraction, fraction 18, and
some F0 proteins were found in the lighter fractions,
fractions 10 and 12, suggesting that some proteins were
independently released probably in heterogeneous VLPs.
Triple expression of M, N, and HN proteins caused less
VLP release in total, but the proteins were fairly concen-
trated to fraction 14 (Fig. 5, M + N + HN). The glyco-
proteins F and HN appeared to guide M and N proteins to
fraction 14.
Simultaneous expression of M, N, F, and HN proteins
resulted in concentration almost all of these proteins to
fraction 14, suggesting formation of homogenous VLPs
with density similar to that of virus particles (Fig. 1B).
Additional expression of the C protein with the four proteins
did not alter the distribution of the proteins, although
amounts of the proteins were increased overall (data not
shown). Convergence by co-expression of viral proteins to
fraction 14, which had the same density as SeV particles,
was apparent when the percent distribution of the M protein
was plotted in a graph (Fig. 5).
Negative staining and electron microscopy demonstrated
that the supernatant from the cells expressing only the M. Plasmids for expression of a single viral protein (M, F, or N) or those for
HN) were introduced into 293T cells and labeled with [35S]cysteine and
by sucrose density equilibrium ultracentrifugation in a 20– 50% continuous
mmunoprecipitation and SDS-PAGE. (Graph) Percent distributions of the M
+ HN, SeV) and this figure (M, M + F, M + N) are plotted in a graph.
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vesicles from the cells expressing M and F proteins had
rough surfaces with some geometric patterns, indicating theFig. 6. Electron microscopy of structures released from transfected cells.
The medium from transfected 293T cells was clarified by low-speed
centrifugation, passed through a 5-Am filter, and centrifuged at 24000 rpm
for 1 h through a 7% (w/w) sucrose cushion. The pellet was resuspended in
PBS, processed for negative staining, and observed by electron microscopy.
(A) Single expression of M. (B) Double expression of M and F. (Inlet)
Magnification of the surface of the VLP. (C) Triple expression of M, N, and
F. Arrowheads indicate nucleocapsid-like structures. (Inlet) Magnification
of the nucleocapsid-like structures.presence of abundant spikes on the surfaces (Fig. 6B).
Furthermore, the vesicles formed by M, F, and N proteins
had nucleocapsid-like structures inside (Fig. 6C). There
were also some structures outside the particles (Fig. 6C).
Co-expression of M, N, F, and HN proteins generated VLPs
similar to virus particles (Fig. 1C), although small vesicles
were also seen in the VLPs (data not shown). There was no
difference between the morphology of VLPs generated by
co-expression of M, N, F, and HN proteins with the C
protein and that without the C protein (data not shown).Discussion
In the present study, we expressed SeV proteins and
produced VLPs. Co-expression of M, N, F, and HN proteins
and sucrose density equilibrium ultracentrifugation concen-
trated these proteins into a common fraction, to which the
authentic virus particles migrated, indicating that these
proteins autonomously assembled into VLPs that are com-
parable to the authentic virus particles in terms of density.
The similar densities seem to reflect the common composi-
tions of the virus particles and the VLPs. The VLP forma-
tion can thus be used as a model for virus assembly and
budding. In this condition, however, protein release was
only one-fifth of that of SeV. A higher level of release,
almost half of the efficiency of SeV, was obtained by co-
expression of C protein together with M, N, F, and HN
proteins. To get closer the efficiency of VLP release to that
of virus release, some other viral proteins or the nucleocap-
sid containing the full-length genomic RNA might be
necessary.
Schmitt et al. (2002) expressed multiple proteins of SV5,
a paramyxovirus classified to the genus distinct from that of
SeV, in 293T cells to generate VLPs (Schmitt et al., 2002).
The study shows that the M protein alone does not result in
generation of VLPs from cells, but co-expression of the N
protein and one of the glycoproteins, F or HN protein,
together with the M protein is necessary for efficient VLP
budding. This situation is different from that of SeV.
Furthermore, the glycoproteins, F and HN proteins, have
similar budding-promoting effects in SV5, whereas in SeV,
the F protein was promoting and the HN protein was
inhibitory for VLP budding. The differences revealed by
VLP formation may indicate differences of mechanism of
virus budding between SV5 and SeV.
An intracellular nucleocapsid structure formed by single
expression of the N protein has been reported in para-
myxoviruses: SeV (Buchholz et al., 1993), measles virus
(Spehner et al., 1991), and Newcastle disease virus (Erring-
ton and Emmerson, 1997). Once formed in cells, the
nucleocapsid-like structure could be a substitute for the
nucleocapsid in VLP budding. We found that the ratio of
the N protein to other viral proteins in VLPs was different to
that in the virus particles; the ratios of the N protein to the M
protein were 1.6:1 in VLPs and 0.7:1 in the virus particles.
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that in the virus, as had been observed in VLP formation in
SV5 (Schmitt et al., 2002). The VLPs may contain nucle-
ocapsid-like structures of various lengths, almost all of
which are probably shorter than the viral nucleocapsid
(15384 bases). Such differences in length may affect the
N protein ratio because difference in length affects the
nucleocapsid incorporation and budding as shown by using
defective interfering particles (Mottet and Roux, 1989).
Interaction between the M protein and viral glycoproteins
has been shown by using biochemical and cell biological
methods (Yoshida et al., 1976, 1979, 1986) and by the use
of live viruses whose cytoplasmic tails of the glycoproteins
were deleted (Fouillot-Coriou and Roux, 2000). Recently,
Ali and Nayak (2000) showed the interaction of M and
glycoproteins in a raft domain by solubilizing cells with a
nonionic detergent and a subsequent sucrose floatation. The
shift of fractions observed in the sucrose density ultracen-
trifugation of VLPs suggested the interaction. On the other
hand, Takimoto et al. (2001) did not suggest the interaction,
based on the observation that the co-expressed and released
M and F proteins were in distinct fractions after sucrose
density equilibrium ultracentrifugation, although they sug-
gested a functional interaction by release acceleration of
both of the proteins. The reason for the contradiction with
ours is unknown. The present study also suggested protein–
protein interaction between M and N. This is consistent with
the previous reports (Coronel et al., 1999, 2001; Yoshida et
al., 1976).
Fouillot-Coriou and Roux (2000) showed by using
recombinant SeVs possessing cytoplasmic tail-deleted gly-
coproteins that a partial deletion of the F tail caused the
virus to bud inefficiently, while the rates of incorporation of
the F protein to other viral proteins were almost constant. It
seems that the F protein is essential for virus budding, as if it
is a part of the budding machinery. On the other hand, the
tail-less HN basically had no effect on virus budding, and
HN mutants are not incorporated in some cases in a
cytoplasmic motif-dependent fashion (Fouillot-Coriou and
Roux, 2000; Takimoto et al., 1998). Furthermore, efficient
budding of an HN-deficient SeV has been reported (Inoue et
al., 2003b; Leyrer et al., 1998; Stricker and Roux, 1991).
These results suggest that SeV F and HN proteins have
different roles in virus budding. Our study showed that the F
protein had a promoting effect on VLP budding, while the
HN protein had an inhibitory effect. Although Takimoto et
al. (2001) demonstrated that the HN protein did not have
such an inhibitory effect on M-driven vesicle release, the
reason of the discrepancy is not known. The HN protein
increased VLPs of uniform density (Fig. 5) and may have
enhanced the integrity of VLPs.
Hasan et al. (2000) reported that SeV lacking all of the
four C proteins yielded less virus particles and that the
particles were irregular in shape, suggesting a role of the C
protein in virus assembly and budding. In the present study,
addition of the C protein to the VLP system enhanced VLPrelease from cells. This is strong evidence that a paramyxo-
virus accessory protein affects virus budding. In infected
cells, the exogenous C protein has a suppressive effect on
RNA synthesis (Curran et al., 1992; Horikami et al., 1997).
Thus, the function of the C protein in virus budding had been
difficult to analyze in virus-infected cells. The present VLP
system could illustrate the action of the C protein on virus
budding. However, the mechanism of acceleration of VLP
release by the C protein is unknown and to be resolved. The
C protein is known to co-localize with the M and HN
proteins in infected cells (Hasan et al., 2000), and it is
thought that the C protein acts as a molecular chaperon to
facilitate assembly of viral proteins by interacting with M
protein. Although the C protein has been shown to interact
with the L protein (Horikami et al., 1997), the interaction
may not be involved in VLP release because the VLP-
forming system in the present study lacked the L protein.
The acceleration of VLP release by the C protein is
limited to only 2- to 3-fold, while a C-knockout virus
suppressed virus formation by ca. 100-fold (Hasan et al.,
2000). Because the C protein has various functions, includ-
ing anti-interferon activity (Garcin et al., 1999; Gotoh et al.,
1999) and inhibition of viral RNA synthesis (Curran et al.,
1992; Horikami et al., 1997), the extremely low yield of C-
knockout virus may be due to the summation of impedi-
ments of these functions in addition to that of the budding-
enhancing activity identified in this work.
In summary, we have established a VLP production
system of SeV. The generated VLPs had density similar to
that of actual virus particles, and the released VLPs were
comparable to the virus particles. A novel finding by using
the VLP system was that the C protein directly facilitated
virus budding. The current VLP system will be useful in
further research on virus budding, including research to
develop antiviral drugs targeting virus assembly and vaccine
development by using VLPs as an immunogen.Materials and methods
Cells and a virus
293T cells, human renal epithelial cells expressing the
SV40 large T antigen, were propagated in Dulbecco’s
modified Eagle’s minimal essential medium (DMEM) sup-
plemented with glutamine and 10% fetal calf serum. Re-
combinant SeV derived from the Z strain (Kato et al., 1996)
was propagated in embryonated chicken eggs as described
previously (Kiyotani et al., 1990).
Plasmids
The plasmids, pCAGGS-M, pCAGGS-N, pCAGGS-F
and pCAGGS-HN, for mammalian expression of SeV
proteins under the chicken h-actin promoter (Niwa et al.,
1991) were described previously (Sakaguchi et al., 1999).
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constructed in this study.
Transfection, infection, and metabolic labeling
Subconfluent 293T cells were transfected with plasmids
by using the FuGENE6 transfection reagent (Roche Diag-
nostics, Indianapolis, IN). For a 60-mm dish, 3.5 Ag of
plasmids were used in cotransfection experiments:
pCAGGS-M, 1 Ag; pCAGGS-F, 1 Ag; pCAGGS-N, 0.5 Ag;
pCAGGS-HN, 0.5 Ag; pCAGGS-C, 0.5 Ag. The plasmid
amounts were determined so that intracellular levels of
protein expression were similar to those in virus-infected
cells. In the case of omission of an expression plasmid, a
vector plasmid, pCAGGS, was added to keep the total
amount of transfected DNA constant. For a 100-mm dish,
a 3-fold larger amount of the plasmids was used. Alterna-
tively, 293T cells were infected with SeV at an m.o.i. of 10.
For metabolic labeling of viral proteins, the medium of
transfected or infected 293T cells was replaced with 1.5 ml
of DMEM containing one-tenth of the normal amounts of
cysteine and methionine and 2.5 MBq/ml of [35S]cysteine
and [35S]methionine mixture ([35S]Pro-mix, Amersham
Biosciences, Piscataway, NJ), together with 10 mU of
bacterial neuraminidase (Roche Diagnostics) after 24 h.
After 48 h, the medium and cells were collected separately.
Sucrose floatation and sucrose density equilibrium
ultracentrifugation
For a sucrose floatation assay, the medium was clarified
by centrifugation at 7000 rpm for 5 min, and 1.4 ml of the
supernatant was mixed with 2.1 g sucrose to adjust its
concentration to 60% (w/w). The supernatant was then
transferred to a centrifuge tube, overlaid with 7 ml of 50%
(w/w) sucrose/phosphate-buffered saline (PBS) and 0.5 ml
of 10% (w/w) sucrose/PBS, and centrifuged at 35000 rpm
for 18 h in a RPS40T rotor (Hitachi, Tokyo, Japan). The top
1.5-ml fraction including the 10% and 50% sucrose bound-
ary was collected and solubilized in a radioimmunoprecipi-
tation assay (RIPA) buffer [10 mM Tris–HCl, pH 7.4, 1%
Triton X-100, 1% sodium deoxycholate, 0.1% sodium
dodecyl sulfate (SDS), and 150 mM NaCl] containing 50
mM iodoacetamide (IAA) and 1 mM phenylmethylsulfonyl
fluoride (PMSF). Cells were solubilized in a RIPA buffer
containing IAA and PMSF and then centrifuged at 15000
rpm for 20 min to remove nuclei and cell debris.
For sucrose density equilibrium ultracentrifugation, the
medium was clarified at 7000 rpm for 5 min and was
layered onto the top of a 20–50% sucrose/PBS linear
density gradient and centrifuged at 35000 rpm for 18 h in
a RPS40T rotor. Fractions were obtained by using an Auto
Densi-Flow fractionator (Labconco, Kansas City, MO).
Density of fractions was measured by weighing each frac-
tion. Proteins in the fractions were solubilized by adding
concentrated RIPA buffer containing IAA and PMSF.Immunoprecipitation and SDS-PAGE
Solubilized proteins in the RIPA buffer were mixed with
2 Al of anti-SeV serum, 1 Al of anti-C serum (kindly
provided by A. Kato), and 30 Al of Protein A Sepharose
beads, followed by agitation for 18 h at 4 jC. Immune
complexes were washed three times with the RIPA buffer,
suspended in SDS sample buffer, and boiled for 3 min as
described previously (Sakaguchi et al., 1996). Proteins were
analyzed by SDS-polyacrylamide gel electrophoresis
(PAGE) using an 11% gel, and protein bands were visual-
ized and quantitated by using a BAS2000 image analyzer
(Fuji Film, Tokyo, Japan). The fraction of viral proteins
released into the medium was calculated basically as the
ratio of the M protein detected in the medium to the total M
protein both in the medium and the cells. Proteins from 1/15
of the cell lysates and those from half of the medium were
run in a lane in these gels.
Electron microscopy
For electron microscopy, subconfluent 293T cells in 100-
mm dishes were transfected with plasmids, and after 48 h, the
media were clarified by low-speed centrifugation and passed
through a Millex-SV filter with a pore size of 5.0 Am
(Millipore, Bedford, MA) to completely remove cells and
then pelleted through a 7% (w/w) sucrose/PBS cushion by
ultracentrifugation at 24000 rpm for 1 h. The pellet was
resuspended in PBS, placed on Formvar-carbon-coated nick-
el grids, stained with 4% uranyl acetate, and examined under
a JEOL JEM-1200EX II transmission electron microscope as
described previously (Uchiyama and Uchida, 1988).Acknowledgments
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